195 results on '"Pirisi, Mario"'
Search Results
2. Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis
3. THU-486-YI A multi-center comparison of Atezolizumab plus Bevacizumab and Lenvatinib as primary systemic therapy for unresectable hepatocellar carcinoma: focus on thrombotic and hemorragic adverse events
4. FRI-028 Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in patients with compensated advanced chronic liver disease of mixed etiology
5. SAT-524 Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study
6. THU-471-YI From randomised clinical trials to clinical practice: a systematic reviewand meta-analysis of real-word data on atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
7. The Potential Role of Vitamin D Supplementation in Cognitive Impairment Prevention
8. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis
9. The Role of New Morphological Parameters Provided by the BC 6800 Plus Analyzer in the Early Diagnosis of Sepsis
10. HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment
11. Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection.
12. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis.
13. Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19
14. From MASH to HCC: the role of Gas6/TAM receptors
15. Unveiling the Mystery of Adult-Onset Still's Disease: a Compelling Case Report
16. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis
17. High Mobility Group Box-1 as a Candidate Biomarker of Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
18. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
19. Unveiling the Mystery of Adult-Onset Still's Disease: A Compelling Case Report.
20. Circadian control of hepatitis B virus replication
21. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19
22. Understanding protection from SARS-CoV-2 using metabolomics
23. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunctionassociated steatohepatitis.
24. SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
25. Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells
26. Feasibility of systemic anti-cancer therapy as an alternative to best supportive care in patients with advanced HCC and Child-Pugh B liver dysfunction
27. Tolerability of first line systemic therapy in elderly patients with advanced hepatocellular carcinoma
28. Spleen stiffness measurement predicts decompensation risk in primary biliary cholangitis
29. Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study
30. COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
31. Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
32. Supplementary Data from Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
33. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
34. Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
35. Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
36. Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.
37. Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development
38. Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis
39. 669 ECHOCARDIOGRAPHIC PREDICTORS FOR MORTALITY IN LIVER TRANSPLANT
40. Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients
41. CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients
42. Vitamin D in Systemic Sclerosis: A Review
43. High reproducibility of spleen stiffness measurement by vibration‐controlled transient elastography with a spleen‐dedicated module
44. 17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon
45. Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort
46. One-Year Follow up of Noninvasive Respiratory Support in General Wards
47. Genes modulating liver fat accumulation and lipogenesis predict development of hepatocellular carcinoma among direct antiviral agents treated cirrhotics C with and without viral clearance
48. Liver stiffness and autoimmune profile in a cohort of patients with systemic sclerosis
49. Potential role of soluble triggering receptor expressed on myeloid cells 2 in risk stratification of patients with hepatocellular carcinoma
50. Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.